Tag: artificial intelligence
AI language model shows “encouraging” potential in locating brain lesions after...
Artificial intelligence (AI) may serve as a future tool for neurologists to help locate the part of the brain in which a stroke occurred,...
Avicenna.AI secures US FDA 510(k) clearance for two AI-powered imaging tools
Avicenna.AI announced today that it has received 510(k) clearance from the US Food and Drug Administration (FDA) for its CINA-ASPECTS and CINA-iPE products.
CINA-ASPECTS is...
Viz.ai gains US FDA 510(k) clearance for intracerebral haemorrhage imaging algorithm
Viz.ai has announced receipt of US Food and Drug Administration (FDA) 510(k) clearance for its Viz Intracerebral Haemorrhage (ICH) Plus algorithm, which is intended...
RapidAI highlights TIMELESS trial publication among other key ISC 2024 presentations
RapidAI has announced the publication of TIMELESS—a randomised trial evaluating the use of tenecteplase in acute ischaemic stroke treatment—in the New England Journal of Medicine...
AI-based decision support system helps improve post-stroke vascular outcomes at three...
Ischaemic stroke survivors who received care recommendations from an artificial intelligence (AI)-based system experienced fewer recurrent strokes and heart attacks, and a lower rate...
New UK NICE guidance endorses AI-derived software in stroke assessments
A new guidance document from the UK National Institute of Health and Care Excellence (NICE) has endorsed National Health Service (NHS) deployment of two...
Hyperfine launches AI-powered eighth generation of Swoop system software
Hyperfine has announced the launch of the artificial intelligence (AI)-powered eighth generation of its Swoop system software.
“The software update on the Swoop system has been...
Researchers receive €10 million grant to create ‘digital twins’ in cerebral...
Researchers in The Netherlands have received a Horizon grant worth €10 million from the European Commission to accelerate development of a technology that could...
RapidAI receives US FDA clearance of AI module for detecting hemispheric...
RapidAI announced today that it has received US Food and Drug Administration (FDA) clearance for Rapid SDH, its artificial intelligence (AI)-powered module for the detection...
Current evidence on AI-based autonomous interventions “inadequate” despite potential benefits
The existing body of evidence supporting artificial intelligence (AI) and the autonomous navigation of endovascular procedures is “inadequate”, despite the theoretical benefits held by...
AI algorithm shows promise for early intracerebral haemorrhage detection in retrospective...
Sheba Medical Center in Tel Aviv, Israel has revealed the results from a “groundbreaking” study in the International Journal of Emergency Medicine, validating an...
Report finds improved thrombectomy access at NHS hospitals using Brainomix’s AI...
More stroke patients are benefitting from life-changing treatment thanks to Brainomix's e-Stroke artificial intelligence (AI) platform, according to a recent report from the Oxford...
Viz.ai announces study findings demonstrating real-world impact of AI-driven stroke technology
Viz.ai has announced the presentation of three new abstracts that demonstrate the real-world impact of the Viz neuro suite at this week’s Society of...
Nicolab and Titan partner to improve prehospital workflows in acute stroke
Nicolab and Titan Neuroscience Research Australia have announced the formal signing of a Memorandum of Understanding (MOU) between the two organisations. The MOU outlines...
RapidAI announces US$75 million growth investment led by Vista Credit Partners
RapidAI today announced US$75 million in Series C funding led by Vista Credit Partners, a subsidiary of Vista Equity Partners and strategic financing partner focused on the...
ChatGPT outperforms medical students and matches residents on neurosurgical board-style questions
An analysis published in the Journal of Neurosurgery, which assessed ChatGPT’s (OpenAI) performance on a surrogate for neurosurgical board-style questions, has found that the...
ConcertAI’s TeraRecon announces release of AI-driven Neuro Suite
ConcertAI's TeraRecon has announced the release of Neuro Suite, its artificial intelligence (AI)-driven clinical suite, which the company claims is purpose-built for disease triage,...
Cercare and ConcertAI partner to improve neurovascular clinical workflows
Cercare Medical has announced it will be bringing its neurovascular clinical workflows into ConcertAI's TeraRecon Eureka clinical artificial intelligence (AI) platform as part of...
RapidAI receives US FDA 510(k) clearance for new imaging product to...
RapidAI announced today that it has received US Food and Drug Administration (FDA) 510(k) clearance for Rapid non-contrast computed tomography (NCCT) Stroke, which is...
Brain Aneurysm Foundation welcomes Carolina Maier to its board of directors
The Brain Aneurysm Foundation (BAF), a leading global research and advocacy organisation committed to improving treatment and care for brain aneurysms, has announced the addition...
Methinks receives CE-mark certification for AI-based stroke triage software
Methinks has announced receipt of a CE mark for its artificial intelligence (AI)-based medical imaging software, Methinks Stroke Suite, following a milestone year of...
Brainomix technology integrated into new UK atrial fibrillation study
Brainomix has announced its involvement in a new study sponsored by the University of Liverpool (Liverpool, UK) focused on post-stroke atrial fibrillation (AF). Sites...
Real-world study demonstrates “highly clinically important” time saving with Viz platform
Viz.ai and TeleSpecialists have announced new data presented at the 2023 International Stroke Conference (ISC; 8–10 February, Dallas, USA) from the VALIDATE study, which...
Avicenna.AI announces total funding of US$10 million after securing Series A...
Avicenna.AI announced today that it has secured a Series A funding round, bringing aggregated investment in the company close to US$10 million. The round...
Challenging the status quo in stroke care
This advertorial is sponsored by Philips.
Time is of the essence when treating a patient who has just experienced a stroke. Every minute counts, and...
AI demonstrates potential to detect carotid artery disease on duplex ultrasound
A prospective study has demonstrated the potential feasibility, applicability and accuracy held by artificial intelligence (AI) in the detection of carotid artery disease on...
Avicenna.AI partners with CARPL.ai to provide AI-powered radiology solutions
Avicenna.AI has today announced a distribution agreement with CARPL.ai—a company providing a technology platform that enables service-provider-oriented testing, validation and deployment of artificial intelligence...
New study finds 85% of aneurysms identified by Viz ANEURYSM had...
Viz.ai has shared highlights from new data set to be presented at next week’s Society of Vascular and Interventional Neuroradiology (SVIN) annual meeting (16–19...
Rapid ICH receives new US FDA clearance with “highest sensitivity and...
RapidAI has announced receipt of US Food and Drug Administration (FDA) 510(k) clearance for the latest release of Rapid ICH—a technology that it describes as...
RAPID Aneurysm programme shows positive early performance in retrospective study
RAPID Aneurysm, a semi-automated artificial intelligence (AI) software programme (RapidAI), is highly accurate in detecting cerebral aneurysms on computed tomography angiography (CTA) imaging, according...
How AI, automation, robotics and other innovations in ultrasound are improving...
Robert Hamilton (Los Angeles, USA) outlines several key milestones in the history of stroke care, and discusses how recent technological advances in this space...
Brainomix awarded tender to roll out AI imaging software across all...
Brainomix has announced that it has been awarded the national tender in Hungary to deploy its artificial intelligence (AI) stroke imaging software across all stroke centres...
SNIS 2022: Research shows AI-based stroke diagnostics can expand access to...
A new study presented at the Society of NeuroInterventional Surgery’s (SNIS) 19th annual meeting (25–29 July, Toronto, Canada) shows that artificial intelligence (AI) technology...
Viz.ai receives US FDA 510(k) clearance for Viz SDH, announces Hyperfine...
Viz.ai today announced it has received US Food and Drug Administration (FDA) 510(k) clearance for Viz Subdural (SDH). The Viz SDH algorithm uses artificial...
RapidAI receives US FDA clearance for Rapid Hyperdensity
RapidAI has announced receipt of US Food and Drug Administration (FDA) clearance for Rapid Hyperdensity—the newest addition to the RapidAI platform. According to the company,...
Artificial intelligence tutoring outperforms expert instructors in neurosurgical training
Against the backdrop of remote learning technologies becoming increasingly important within medical training during the COVID-19 pandemic, a new study has found that—in a...
Avicenna.AI signs distribution agreement with Sectra for neurovascular AI solutions
Avicenna.AI has announced a signed distribution agreement with Sectra—an international medical imaging information technology (IT) and cybersecurity company. The agreement will see Avicenna’s AI...
Pushing the boundaries of aneurysm detection, monitoring and care with AI
Alejandro Spiotta (Medical University of South Carolina, Charleston, USA) outlines what he believes could be the next frontier in cerebral aneurysm care—artificial intelligence (AI)—and...
Viz.ai receives FDA 510(k) clearance for cerebral aneurysm detection algorithm
Viz.ai has received US Food and Drug Administration (FDA) 510(k) clearance for Viz ANEURYSM—a new algorithm that uses artificial intelligence (AI) to detect suspected...
RapidAI announces Karim Karti as new CEO
RapidAI has announced Karim Karti, former president and CEO of GE Healthcare Imaging, as the company’s chief executive officer (CEO).
“Karim’s tremendous global experience in...
CyberKnife robotic radiosurgery system approved for treatment of trigeminal neuralgia in...
Accuray has received approval from the Japanese Ministry of Health, Labor and Welfare (Shonin) to market the CyberKnife robotic radiosurgery system for the treatment of...
Time savings, cost reductions and improved patient outcomes all key benefits...
Artificial intelligence (AI) and the role it can play in improving acute ischaemic stroke care protocols took centre stage at the Barts Research and...
AI holds the key to timely interventions in a field where...
This advertorial is sponsored by Nicolab.
In 2021, the Royal Infirmary of Edinburgh and networking hospitals are implementing StrokeViewer (Nicolab)—which is an artificial intelligence (AI)...
Viz.ai debuts AI-powered cerebral aneurysm detection technology at SVIN 2021
At this year’s Society of Vascular and Interventional Neurology annual meeting (SVIN 2021; 17–20 November, Phoenix, USA and virtual), Viz.ai introduced Viz ANX, a...
New study finds e-Stroke software shortens treatment times and improves functional...
A new study presented at the 13th World Stroke Congress (WSC 2021; 28–29 October, virtual) found that the implementation of Brainomix's e-Stroke software resulted in...
Neuvotion secures more than US$1 million in seed funding to commercialise...
Neuvotion has announced that it has received more than US$1 million in seed funding. The Long Island Angel Network, an organised group of individual,...
Sensome begins first-in-human trial of AI-powered stroke guidewire
Sensome has announced enrolment of the first patients in the multicentre, first-in-human CLOT OUT study, which will evaluate the safety and performance of the...
ESOC 2021: AI can calculate personalised risk of having another stroke
Artificial intelligence (AI) can be used to give stroke patients a personalised and more accurate assessment of their risk of suffering a recurrence, according...
Qure.ai lands second FDA clearance for AI-based brain scan technology
Qure.ai has announced US Food and Drug Administration (FDA) 510(k) clearance for its brain computed tomography (CT) quantification product qER-Quant. Clinicians in the USA...
SNIS 2021: Remote stroke interventions raise several unique ethical challenges
At the Society of NeuroInterventional Surgery’s 18th annual meeting (SNIS; July 26–29 2021, Colorado Springs, USA and virtual), Jeffrey Saver, professor of Neurology at...
How stimulation is changing the future of mental health treatment
Daniel Månsson (Flow Neuroscience, Malmö, Sweden) outlines the benefits held by transcranial direct-current stimulation (tDCS) in the treatment of depression—and how clinical evidence supporting...
Brainomix launches AI stroke software across Poland under POLKARD initiative
Brainomix has deployed its flagship artificial intelligence (AI)-based e-Stroke software across the majority of the largest comprehensive stroke centres in Poland, allowing the company...
Viz.ai receives CE mark to bring AI-powered stroke care software to...
Viz.ai has been awarded a CE mark for its artificial intelligence (AI)-powered stroke care software, affirming its conformity with European health, safety and environmental...
Sensome’s AI-powered stroke guidewire granted FDA Breakthrough Device designation
Sensome has announced its Clotild Smart Guidewire System—designed to improve the treatment of ischaemic stroke patients—has been granted a Breakthrough Device designation by the...
Stryker partners with Brainomix for AI stroke software
Stryker has announced a new partnership with Brainomix that provides an option for European customers to purchase Brainomix’s e-Stroke software.
According to a press release...
PreSize Neurovascular software launched at first UK NHS hospital
Doctors at St George’s Hospital in London, UK are set to become the first within the UK National Health Service (NHS) to begin using Oxford Heartbeat’s...
ESO-WSO: AI can be used for automatic segmentation of stroke infract...
A study presented by Kelvin Wong (Houston Methodist, Houston, US) at the European Stroke Organisation and the World Stroke Organization joint virtual conference (ESO-WSO...
Viz.ai adds new capabilities to its AI stroke platform
Viz.ai has launched the next generation of its synchronized care platform for stroke. Viz.ai incorporates cutting edge artificial intelligence with HIPAA-compliant communication to allow...
Philips extends AI portfolio with launch of IntelliSpace AI Workflow Suite...
Philips announces the launch of IntelliSpace AI Workflow Suite to enable healthcare providers to seamlessly integrate AI applications into the imaging workflow. Part of...
Viz.ai launches a range of new AI features
Viz.ai has announced a number of new features at the Society of Vascular and Interventional Neurology (SVIN) annual meeting in Atlanta, USA (20–23 November,...
Although “unperfected”, AI has the potential to accelerate and synchronise stroke...
A recently published systematic review reveals that artificial intelligence (AI) is rapidly being used by major medical centres to identify large vessel occlusions (LVO)...
RAPID platform expands to address haemorrhagic stroke
iSchemaView has launched the newest addition to the RAPID platform, RAPID ICH at the 2019 Congress of Neurological Surgeons (CNS) Annual Meeting (19–23 October,...
Guerbet signs agreement with icometrix for the distribution of icobrain, an...
Guerbet announces that it has signed an exclusive agreement with icometrix for the distribution in France, Italy and Brazil of icobrain, their Saas (Software...
Aidoc releases complete AI package to speed identification and treatment of...
Aidoc, provider of artificial intelligence (AI) solutions to radiologists, has announced the release of its complete AI package for the identification and triage of...
Canon Medical receives FDA clearance for deep convolutional neural network image...
Building on its advanced image reconstruction technologies, Canon Medical Systems USA has received 510(k) clearance on its new deep convolutional neural network (DCNN) image...
New AI tool for detecting cerebral aneurysms enhances clinicians’ accuracy
Through developing a deep learning model to automatically detect clinically significant intracranial aneurysms on computed tomography (CT) angiography, clinicians’ sensitivity, accuracy, and interrater reliability...
Viz.ai and NICO announce collaboration to speed patient recruitment in the...
Viz.ai and NICO have announced a collaboration to incorporate a new innovative clinical trial recruitment software from Viz.ai into the seminal ENRICH study which...
New results demonstrate ability to automatically detect suspected large-vessel occlusion stroke...
Viz.ai has further advanced the field of stroke imaging and workflow by developing a novel method for the detection of signs of large vessel...
Brainomix secures £7m investment to tackle strokes with AI
Brainomix, a medical imaging company using artificial intelligence (AI) for the fast diagnosis and treatment of stroke victims, has attracted £7m of investment to...
